Stratum Market Research
Contact

Healthcare & Life SciencesUnited StatesUpdated 27 Oct 2026

US AI Medical Imaging Market 2026: size, data and top companies

The FDA has authorized over 1,600 AI-enabled medical devices for the US market as of September 2026. Radiology accounts for 1,230 of the 1,614 devices counted through June 2026, or 76%. GE HealthCare holds the most authorizations of any vendor, at 134.

Region
United States
Evidence
7 sourced figures from 3 sources
Last checked
27 Oct 2026

1,230devices

FDA-authorized AI-enabled radiology devices (through June 2026)

1,600+devices

The FDA has authorized over 1,600 AI-enabled medical devices for marketing in the United States as of September 2026.

1,614devices

The FDA's AI-enabled device list counted 1,614 authorized devices through June 2026.

1,451devices

The FDA's list counted 1,451 AI-enabled devices through the end of 2025, 1,104 of them in radiology.

Illustrative

Why this market is moving now

  • The FDA authorized 92 AI-enabled devices in Q1 2026 and 89 in Q2 2026.
  • The FDA's cumulative list passed 1,600 devices by September 2026.

Key figures

Each figure names the source it came from. Open the source list below to read the quoted line.

FigureValueYearSource
The FDA has authorized over 1,600 AI-enabled medical devices for marketing in the United States as of September 2026.1,600+ devices2026U.S. Food and Drug Administration
The FDA's AI-enabled device list counted 1,614 authorized devices through June 2026.1,614 devices2026The Imaging Wire
Radiology accounts for 1,230 of the FDA-authorized AI-enabled devices through June 2026, or 76%.1,230 devices2026The Imaging Wire
The FDA's list counted 1,451 AI-enabled devices through the end of 2025, 1,104 of them in radiology.1,451 devices2025The Imaging Wire
The FDA authorized 89 AI-enabled devices in the second quarter of 2026 and 92 in the first quarter, with radiology making up 66 of the Q2 devices.89 devices (Q2 2026)2026The Imaging Wire
GE HealthCare has 134 FDA-authorized AI-enabled devices, the most of any vendor; Siemens Healthineers has 101 and Philips 62 (counts include acquired companies).134 devices (GE HealthCare)2026The Imaging Wire
Radiology's share of AI-enabled device authorizations was 80% in 2023, 73% in 2024 and 75% for all of 2025.75 % radiology share of 2025 authorizations2025The Imaging Wire

Sources and method

The figures on this page come from the public sources listed below. Read how we work.

  1. U.S. Food and Drug Administration: Artificial Intelligence-Enabled Medical Devices (2026-09-22)
    Quoted lines
    • Figure 1The FDA has authorized over 1,600 AI-enabled medical devices for marketing in the United States as of September 2026.
  2. The Imaging Wire: Top 10 AI Vendors by FDA Approvals (2026-09-14)
    Quoted lines
    • Figure 2Authorized 1,614 AI-enabled medical devices since it started keeping track
    • Figure 3Authorized 1,230 radiology devices, or 76% of all AI-enabled medical authorizations.
    • Figure 5In the second quarter of 2026, the FDA authorized 89 AI-enabled medical devices, slightly fewer than the 92 devices it authorized
    • Figure 6GE HealthCare: 134
  3. The Imaging Wire: FDA Updates AI List with New Clearances (2026-03-12)
    Quoted lines
    • Figure 4Authorized 1,451 AI-enabled medical devices since it began keeping track in 1995.
    • Figure 7For all of 2025, radiology secured 75% of authorizations, compared to 73% for all of 2024 and 80% for 2023.

Companies to watch

GE HealthCare

Holds the most FDA-listed AI-enabled devices, 134 (includes acquired companies).

Siemens Healthineers

Second by FDA-listed AI-enabled devices, with 101.

Philips

Third by FDA-listed AI-enabled devices, with 62.

What the full report covers

  1. 01Executive summary
    The answer in one page: size, direction and what moves it
  2. 02Market definition and scope
    What is in and out of the United States market
  3. 03Market size, 2021 to 2025
    Historical series and growth rates
  4. 04Outlook to 2031
    Base, low and high scenarios with stated assumptions
  5. 05Rules, policy and deadlines
    Regulation and programmes that change demand
  6. 06Drivers and barriers
    What accelerates or slows adoption, by customer segment
  7. 07Prices, costs and margins
    Unit economics where public data allows
  8. 08Competitive landscape
    8 to 12 company profiles with recent moves
  9. 09Opportunities and risks
    For new entrants, suppliers and investors
  10. 10Method and sources
    Every assumption and source, listed

Included with the full report

  • PDF report, 40 to 60 pages
  • Excel data pack
  • Ready-to-use charts
  • Method note and assumptions
  • Written to order in 5 working days
Compare the editions

Frequently asked questions

How many AI medical devices has the FDA authorized?

The FDA says it has authorized over 1,600 AI-enabled medical devices as of September 2026. The Imaging Wire's read of the list counts 1,614 through June 2026.

How many of them are for radiology?

The Imaging Wire counts 1,230 radiology devices, or 76% of all AI-enabled authorizations, through June 2026.

Who has the most FDA-authorized AI imaging devices?

GE HealthCare has 134, followed by Siemens Healthineers with 101 and Philips with 62, per The Imaging Wire's analysis of the FDA list. Counts include acquired companies.

How fast are new AI devices being authorized?

The FDA authorized 92 AI-enabled devices in Q1 2026 and 89 in Q2 2026, with radiology making up 66 of the Q2 devices.

What was the count at the end of 2025?

The Imaging Wire reported 1,451 AI-enabled devices on the FDA list through the end of 2025, including 1,104 in radiology.

Free sample

Get a free sample of this report

We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.

  • Full table of contents
  • Two sample chapters
  • Method note and data outline
A market, a region or the decision you are making helps us pick the right chapters.

We use your details only to reply. See our privacy policy.

Full report $3,450Choose an edition